Global Neurodegenerative Disease Treatment Drug Market Growth (Status and Outlook) 2026-2032
The global Neurodegenerative Disease Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Neurodegenerative Disease Treatment Drug Industry Forecast” looks at past sales and reviews total world Neurodegenerative Disease Treatment Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurodegenerative Disease Treatment Drug sales for 2026 through 2032. With Neurodegenerative Disease Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurodegenerative Disease Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Neurodegenerative Disease Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurodegenerative Disease Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurodegenerative Disease Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurodegenerative Disease Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurodegenerative Disease Treatment Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurodegenerative Disease Treatment Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Neurodegenerative Disease Treatment Drug Industry Forecast” looks at past sales and reviews total world Neurodegenerative Disease Treatment Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurodegenerative Disease Treatment Drug sales for 2026 through 2032. With Neurodegenerative Disease Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurodegenerative Disease Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Neurodegenerative Disease Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurodegenerative Disease Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurodegenerative Disease Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurodegenerative Disease Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurodegenerative Disease Treatment Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurodegenerative Disease Treatment Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- N-methyl-D-aspartate Receptor antagonists
- Cholinesterase Inhibitors
- Dopamine Agonists
- Immunomodulatory Drugs
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbvie Inc.
- Amneal Pharmaceuticals Inc.
- Boehringer Ingelheim International Gmbh
- Hoffmann-La Roche
- Merck & Co. Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Treatment Drug Market Size (2021-2032)
2.1.2 Neurodegenerative Disease Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neurodegenerative Disease Treatment Drug by Country/Region (2021, 2025 & 2032)
2.2 Neurodegenerative Disease Treatment Drug Segment by Type
2.2.1 N-methyl-D-aspartate Receptor antagonists
2.2.2 Cholinesterase Inhibitors
2.2.3 Dopamine Agonists
2.2.4 Immunomodulatory Drugs
2.2.5 Others
2.2.6 Neurodegenerative Disease Treatment Drug Market Size by Type
2.2.6.1 Neurodegenerative Disease Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
2.3 Neurodegenerative Disease Treatment Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Neurodegenerative Disease Treatment Drug Market Size by Application
2.3.4.1 Neurodegenerative Disease Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
3 NEURODEGENERATIVE DISEASE TREATMENT DRUG MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Treatment Drug Market Size Market Share by Player
3.1.1 Global Neurodegenerative Disease Treatment Drug Revenue by Player (2021-2026)
3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player (2021-2026)
3.2 Global Neurodegenerative Disease Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE TREATMENT DRUG BY REGION
4.1 Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026)
4.2 Global Neurodegenerative Disease Treatment Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.4 APAC Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.5 Europe Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026)
5.2 Americas Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
5.3 Americas Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026)
6.2 APAC Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
6.3 APAC Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026)
7.2 Europe Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease Treatment Drug by Region (2021-2026)
8.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE TREATMENT DRUG MARKET FORECAST
10.1 Global Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.1.1 Global Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.1.2 Americas Neurodegenerative Disease Treatment Drug Forecast
10.1.3 APAC Neurodegenerative Disease Treatment Drug Forecast
10.1.4 Europe Neurodegenerative Disease Treatment Drug Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Treatment Drug Forecast
10.2 Americas Neurodegenerative Disease Treatment Drug Forecast by Country (2027-2032)
10.2.1 United States Market Neurodegenerative Disease Treatment Drug Forecast
10.2.2 Canada Market Neurodegenerative Disease Treatment Drug Forecast
10.2.3 Mexico Market Neurodegenerative Disease Treatment Drug Forecast
10.2.4 Brazil Market Neurodegenerative Disease Treatment Drug Forecast
10.3 APAC Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.3.1 China Neurodegenerative Disease Treatment Drug Market Forecast
10.3.2 Japan Market Neurodegenerative Disease Treatment Drug Forecast
10.3.3 Korea Market Neurodegenerative Disease Treatment Drug Forecast
10.3.4 Southeast Asia Market Neurodegenerative Disease Treatment Drug Forecast
10.3.5 India Market Neurodegenerative Disease Treatment Drug Forecast
10.3.6 Australia Market Neurodegenerative Disease Treatment Drug Forecast
10.4 Europe Neurodegenerative Disease Treatment Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Neurodegenerative Disease Treatment Drug Forecast
10.4.2 France Market Neurodegenerative Disease Treatment Drug Forecast
10.4.3 UK Market Neurodegenerative Disease Treatment Drug Forecast
10.4.4 Italy Market Neurodegenerative Disease Treatment Drug Forecast
10.4.5 Russia Market Neurodegenerative Disease Treatment Drug Forecast
10.5 Middle East & Africa Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Neurodegenerative Disease Treatment Drug Forecast
10.5.2 South Africa Market Neurodegenerative Disease Treatment Drug Forecast
10.5.3 Israel Market Neurodegenerative Disease Treatment Drug Forecast
10.5.4 Turkey Market Neurodegenerative Disease Treatment Drug Forecast
10.6 Global Neurodegenerative Disease Treatment Drug Forecast by Type (2027-2032)
10.7 Global Neurodegenerative Disease Treatment Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neurodegenerative Disease Treatment Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Information
11.1.2 Abbvie Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbvie Inc. Main Business Overview
11.1.5 Abbvie Inc. Latest Developments
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Information
11.2.2 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Amneal Pharmaceuticals Inc. Main Business Overview
11.2.5 Amneal Pharmaceuticals Inc. Latest Developments
11.3 Boehringer Ingelheim International Gmbh
11.3.1 Boehringer Ingelheim International Gmbh Company Information
11.3.2 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product Offered
11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Boehringer Ingelheim International Gmbh Main Business Overview
11.3.5 Boehringer Ingelheim International Gmbh Latest Developments
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Information
11.4.2 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product Offered
11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Hoffmann-La Roche Main Business Overview
11.4.5 Hoffmann-La Roche Latest Developments
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Information
11.5.2 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Merck & Co. Inc. Main Business Overview
11.5.5 Merck & Co. Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Treatment Drug Market Size (2021-2032)
2.1.2 Neurodegenerative Disease Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neurodegenerative Disease Treatment Drug by Country/Region (2021, 2025 & 2032)
2.2 Neurodegenerative Disease Treatment Drug Segment by Type
2.2.1 N-methyl-D-aspartate Receptor antagonists
2.2.2 Cholinesterase Inhibitors
2.2.3 Dopamine Agonists
2.2.4 Immunomodulatory Drugs
2.2.5 Others
2.2.6 Neurodegenerative Disease Treatment Drug Market Size by Type
2.2.6.1 Neurodegenerative Disease Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
2.3 Neurodegenerative Disease Treatment Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Neurodegenerative Disease Treatment Drug Market Size by Application
2.3.4.1 Neurodegenerative Disease Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
3 NEURODEGENERATIVE DISEASE TREATMENT DRUG MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Treatment Drug Market Size Market Share by Player
3.1.1 Global Neurodegenerative Disease Treatment Drug Revenue by Player (2021-2026)
3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player (2021-2026)
3.2 Global Neurodegenerative Disease Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE TREATMENT DRUG BY REGION
4.1 Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026)
4.2 Global Neurodegenerative Disease Treatment Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.4 APAC Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.5 Europe Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026)
5.2 Americas Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
5.3 Americas Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026)
6.2 APAC Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
6.3 APAC Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026)
7.2 Europe Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease Treatment Drug by Region (2021-2026)
8.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE TREATMENT DRUG MARKET FORECAST
10.1 Global Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.1.1 Global Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.1.2 Americas Neurodegenerative Disease Treatment Drug Forecast
10.1.3 APAC Neurodegenerative Disease Treatment Drug Forecast
10.1.4 Europe Neurodegenerative Disease Treatment Drug Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Treatment Drug Forecast
10.2 Americas Neurodegenerative Disease Treatment Drug Forecast by Country (2027-2032)
10.2.1 United States Market Neurodegenerative Disease Treatment Drug Forecast
10.2.2 Canada Market Neurodegenerative Disease Treatment Drug Forecast
10.2.3 Mexico Market Neurodegenerative Disease Treatment Drug Forecast
10.2.4 Brazil Market Neurodegenerative Disease Treatment Drug Forecast
10.3 APAC Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.3.1 China Neurodegenerative Disease Treatment Drug Market Forecast
10.3.2 Japan Market Neurodegenerative Disease Treatment Drug Forecast
10.3.3 Korea Market Neurodegenerative Disease Treatment Drug Forecast
10.3.4 Southeast Asia Market Neurodegenerative Disease Treatment Drug Forecast
10.3.5 India Market Neurodegenerative Disease Treatment Drug Forecast
10.3.6 Australia Market Neurodegenerative Disease Treatment Drug Forecast
10.4 Europe Neurodegenerative Disease Treatment Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Neurodegenerative Disease Treatment Drug Forecast
10.4.2 France Market Neurodegenerative Disease Treatment Drug Forecast
10.4.3 UK Market Neurodegenerative Disease Treatment Drug Forecast
10.4.4 Italy Market Neurodegenerative Disease Treatment Drug Forecast
10.4.5 Russia Market Neurodegenerative Disease Treatment Drug Forecast
10.5 Middle East & Africa Neurodegenerative Disease Treatment Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Neurodegenerative Disease Treatment Drug Forecast
10.5.2 South Africa Market Neurodegenerative Disease Treatment Drug Forecast
10.5.3 Israel Market Neurodegenerative Disease Treatment Drug Forecast
10.5.4 Turkey Market Neurodegenerative Disease Treatment Drug Forecast
10.6 Global Neurodegenerative Disease Treatment Drug Forecast by Type (2027-2032)
10.7 Global Neurodegenerative Disease Treatment Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neurodegenerative Disease Treatment Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Information
11.1.2 Abbvie Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbvie Inc. Main Business Overview
11.1.5 Abbvie Inc. Latest Developments
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Information
11.2.2 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Amneal Pharmaceuticals Inc. Main Business Overview
11.2.5 Amneal Pharmaceuticals Inc. Latest Developments
11.3 Boehringer Ingelheim International Gmbh
11.3.1 Boehringer Ingelheim International Gmbh Company Information
11.3.2 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product Offered
11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Boehringer Ingelheim International Gmbh Main Business Overview
11.3.5 Boehringer Ingelheim International Gmbh Latest Developments
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Information
11.4.2 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product Offered
11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Hoffmann-La Roche Main Business Overview
11.4.5 Hoffmann-La Roche Latest Developments
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Information
11.5.2 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product Offered
11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Merck & Co. Inc. Main Business Overview
11.5.5 Merck & Co. Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurodegenerative Disease Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neurodegenerative Disease Treatment Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of N-methyl-D-aspartate Receptor antagonists
Table 4. Major Players of Cholinesterase Inhibitors
Table 5. Major Players of Dopamine Agonists
Table 6. Major Players of Immunomodulatory Drugs
Table 7. Major Players of Others
Table 8. Neurodegenerative Disease Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Table 11. Neurodegenerative Disease Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Table 14. Global Neurodegenerative Disease Treatment Drug Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player (2021-2026)
Table 16. Neurodegenerative Disease Treatment Drug Key Players Head office and Products Offered
Table 17. Neurodegenerative Disease Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Table 22. Global Neurodegenerative Disease Treatment Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Country (2021-2026)
Table 26. Americas Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Table 28. Americas Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Table 30. APAC Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Table 32. APAC Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Country (2021-2026)
Table 36. Europe Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease Treatment Drug
Table 42. Key Market Challenges & Risks of Neurodegenerative Disease Treatment Drug
Table 43. Key Industry Trends of Neurodegenerative Disease Treatment Drug
Table 44. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Abbvie Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 49. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 50. Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Abbvie Inc. Main Business
Table 52. Abbvie Inc. Latest Developments
Table 53. Amneal Pharmaceuticals Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 54. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 55. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Amneal Pharmaceuticals Inc. Main Business
Table 57. Amneal Pharmaceuticals Inc. Latest Developments
Table 58. Boehringer Ingelheim International Gmbh Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 59. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product Offered
Table 60. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Boehringer Ingelheim International Gmbh Main Business
Table 62. Boehringer Ingelheim International Gmbh Latest Developments
Table 63. Hoffmann-La Roche Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 64. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product Offered
Table 65. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Hoffmann-La Roche Main Business
Table 67. Hoffmann-La Roche Latest Developments
Table 68. Merck & Co. Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 69. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 70. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Merck & Co. Inc. Main Business
Table 72. Merck & Co. Inc. Latest Developments
Table 1. Neurodegenerative Disease Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neurodegenerative Disease Treatment Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of N-methyl-D-aspartate Receptor antagonists
Table 4. Major Players of Cholinesterase Inhibitors
Table 5. Major Players of Dopamine Agonists
Table 6. Major Players of Immunomodulatory Drugs
Table 7. Major Players of Others
Table 8. Neurodegenerative Disease Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Table 11. Neurodegenerative Disease Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Table 14. Global Neurodegenerative Disease Treatment Drug Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player (2021-2026)
Table 16. Neurodegenerative Disease Treatment Drug Key Players Head office and Products Offered
Table 17. Neurodegenerative Disease Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Table 22. Global Neurodegenerative Disease Treatment Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Country (2021-2026)
Table 26. Americas Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Table 28. Americas Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Table 30. APAC Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Table 32. APAC Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Country (2021-2026)
Table 36. Europe Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease Treatment Drug
Table 42. Key Market Challenges & Risks of Neurodegenerative Disease Treatment Drug
Table 43. Key Industry Trends of Neurodegenerative Disease Treatment Drug
Table 44. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Neurodegenerative Disease Treatment Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Abbvie Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 49. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 50. Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Abbvie Inc. Main Business
Table 52. Abbvie Inc. Latest Developments
Table 53. Amneal Pharmaceuticals Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 54. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 55. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Amneal Pharmaceuticals Inc. Main Business
Table 57. Amneal Pharmaceuticals Inc. Latest Developments
Table 58. Boehringer Ingelheim International Gmbh Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 59. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product Offered
Table 60. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Boehringer Ingelheim International Gmbh Main Business
Table 62. Boehringer Ingelheim International Gmbh Latest Developments
Table 63. Hoffmann-La Roche Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 64. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product Offered
Table 65. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Hoffmann-La Roche Main Business
Table 67. Hoffmann-La Roche Latest Developments
Table 68. Merck & Co. Inc. Details, Company Type, Neurodegenerative Disease Treatment Drug Area Served and Its Competitors
Table 69. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product Offered
Table 70. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Merck & Co. Inc. Main Business
Table 72. Merck & Co. Inc. Latest Developments
LIST OF FIGURES
Figure 1. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neurodegenerative Disease Treatment Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neurodegenerative Disease Treatment Drug Sales Market Share by Country/Region (2025)
Figure 8. Neurodegenerative Disease Treatment Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type in 2025
Figure 10. Neurodegenerative Disease Treatment Drug in Hospital
Figure 11. Global Neurodegenerative Disease Treatment Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Neurodegenerative Disease Treatment Drug in Clinic
Figure 13. Global Neurodegenerative Disease Treatment Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Neurodegenerative Disease Treatment Drug in Others
Figure 15. Global Neurodegenerative Disease Treatment Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application in 2025
Figure 17. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player in 2025
Figure 18. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Neurodegenerative Disease Treatment Drug Value Market Share by Country in 2025
Figure 24. United States Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Region in 2025
Figure 29. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Country in 2025
Figure 38. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 61. China Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 65. India Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 68. France Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 1. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neurodegenerative Disease Treatment Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neurodegenerative Disease Treatment Drug Sales Market Share by Country/Region (2025)
Figure 8. Neurodegenerative Disease Treatment Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Type in 2025
Figure 10. Neurodegenerative Disease Treatment Drug in Hospital
Figure 11. Global Neurodegenerative Disease Treatment Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Neurodegenerative Disease Treatment Drug in Clinic
Figure 13. Global Neurodegenerative Disease Treatment Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Neurodegenerative Disease Treatment Drug in Others
Figure 15. Global Neurodegenerative Disease Treatment Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Application in 2025
Figure 17. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Player in 2025
Figure 18. Global Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Neurodegenerative Disease Treatment Drug Value Market Share by Country in 2025
Figure 24. United States Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Region in 2025
Figure 29. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Country in 2025
Figure 38. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Neurodegenerative Disease Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 61. China Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 65. India Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 68. France Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Neurodegenerative Disease Treatment Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Neurodegenerative Disease Treatment Drug Market Size 2027-2032 ($ millions)
